CN106676157A - Application of legionella thalli in preparing amino acid profile transformation agent - Google Patents

Application of legionella thalli in preparing amino acid profile transformation agent Download PDF

Info

Publication number
CN106676157A
CN106676157A CN201710088482.4A CN201710088482A CN106676157A CN 106676157 A CN106676157 A CN 106676157A CN 201710088482 A CN201710088482 A CN 201710088482A CN 106676157 A CN106676157 A CN 106676157A
Authority
CN
China
Prior art keywords
legionella
amino acid
thalline
application
acid profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710088482.4A
Other languages
Chinese (zh)
Inventor
李水红
段元润
赵飞骏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South China
Original Assignee
University of South China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South China filed Critical University of South China
Priority to CN201710088482.4A priority Critical patent/CN106676157A/en
Publication of CN106676157A publication Critical patent/CN106676157A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/12Methionine; Cysteine; Cystine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses an application of legionella thalli in preparing an amino acid profile transformation agent and use thereof and relates to the field of applied microbiology. The application comprises the steps of: nutrition adaptive screening of a strain, bacterial cultivation and proliferation, amino acid profile transformation and product recovery and the like. The agent disclosed by the invention is simple in process, low in cost, high in product yield and free of environmental pollution, so that the amino acid profile transformation agent has a good industrial application prospect.

Description

Legionella thalline prepares the application of amino acid configuration transferring reagent
Technical field
The present invention relates to a kind of be converted into L-type aminoacid using legionella thalline and its metabolite by D-L type aminoacid Method.
Background technology
In nature, the aminoacid for constituting protein is usually L-configuration.The method of Amino acid synthesis generally includes chemical conjunction Cheng Fa, microbe fermentation method and enzyme process.Amino acid classes are more obtained by chemical synthesiss, but the racemic modification of synthesis(D-L Aminoacid)The aminoacid that single configuration could be obtained through Chiral Separation is needed, and this process cost is sufficiently expensive.Fermentation Method is the ability that a kind of utilization microorganism has various aminoacid needed for synthesis itself, and by fermentation technology the one of aminoacid is prepared Plant common method.Although the method raw material is cheap, the amino acid products for preparing are single, and purity is not high, have association aminoacid to produce, And the selection-breeding of fermented bacterium more trouble is not easy to control.Enzyme process be Organic substance is transformed into by various active enzyme needed for A kind of method of aminoacid.Although this method can obtain the L-type aminoacid of 100 % purity, during inevitably result in the mistake of enzyme It is living, and enzyme regeneration cost is still expensive.The present invention directly utilizes the legionella thalline wet product through nutrition screening, without the need for fine Isolate and purify, you can efficiently realize that amino acid racemization body selectivity configuration splits, with biological method chemosynthesis are solved Method later stage Chiral Separation is difficult, the problem of high cost.
The content of the invention
Technical problem:
To make up, existing Amino acid synthesis technical costss are expensive, and commercial production is worth low deficiency, the invention provides a kind of profit With legionella thalline wet product as amino acid configuration transferring reagent, the D-L types aminoacid for directly obtaining to chemosynthesis carries out structure Type is changed, and prepares highly purified l-amino acid.The product purity that the method process is simple, cost are relatively low, obtain is high, possesses wide Industrial applications prospect.
Technical scheme:
The present inventor according to modern biotechnology theory, with industrial microorganism key technology and modern analysis detection technique, so as to Complete the present invention.
It is an object of the invention to provide a kind of can be by a kind of amino acid converting biological method for L-type aminoacid of D-L types.Tool Body technology process is as follows:
1. the condition of culture of antibacterial
The fluid medium of suitable legionella fast-growth is prepared in accordance with the following methods.Weigh 10g N- (2- acetylaminos) -2- Aminoethane sulphonic acid (N- (2-Acetamido) -2-aminoethanesulfonic acid; ACES buffer);10g ferment During female extract (Yeast extract) is dissolved to 800mL distilled waters, pH value is adjusted to 6.9-7.0, high steam goes out Bacterium, cools down standby.In addition 5g bovin serum albumin (Bovin serum albumin), the Guang ammonia of 0.4g L- half are weighed respectively Acid hydrochloride (L-cysteine hydrochloride), 0.25g ferrous pyrophosphates (Ferrous pyrophosphate), In being completely dissolved in 200 mL distilled waters, by the microporous filter membrane sucking filtration in 0.22 μm of aperture it is degerming after, be added to and above-mentioned sterilize In standby solution, mixing is obtained final product.Flat board used by growth of the bacterium in solid agar adopts BCYE agar plates(Existing business Product).
2. the nutrition flexibility screening of strain
By legionella pneumophilia standard strain ATCC33152(Purchased from American Type Culture Collecti)It is inoculated in and is additionally supplemented with 10 % In the aforesaid liquid culture of D-L type cysteine, in 37 DEG C, 5% CO2Cultivate in incubator, every 7 days, draw 1mL and pass on Continue to cultivate into fresh above-mentioned culture medium, repeat aforesaid operations more than 10 times, you can obtain and have compared with homoamino acid configuration The strain of conversion efficiency.The mutant strain is properly preserved in into -70 DEG C of refrigerators standby.
3. antibacterial is passed on and propagation
Above-mentioned operation is supported after the actication of culture of adaptability screening, the fresh training of the liquid without D-L type cysteine is inoculated in In foster base (described in technique 1), in being placed in 37 DEG C of constant temperature track incubators, the h of 200rmp concussion and cultivates 48, to culture fluid The middle ammonium sulfate for adding isopyknic 3mol/L so as in albumen or enzyme be deposited to bottom, then it is centrifuged in 10000 rmp 30 min, thalline and albumen therein or enzyme are deposited in ttom of pipe, will precipitate wet body and collect, and are preserved in -70 DEG C of refrigerators It is standby.
4. amino acid configuration is changed and Product recycling
The racemic modification D-L type cysteine obtained to chemosynthesis is configured to aqueous solution, and it is heavy to be added thereto to above-mentioned wet body Starch(Comprising the protein ingredient in thalline and metabolite or other compositions), addition is 100 mg/mL, and solution is placed in 37 DEG C, the h of concussion and cultivate 24 in the shaking table of 200 rmp.Add isopyknic 3 mol/L ammonium sulfate in solution again, 10000 Rmp is centrifuged after 30 min, discards precipitation, and supernatant is processed by ion exchange, can harvest purity up to more than 97% L-type cysteine.
Beneficial effect:
Racemate resolution method involved in the present invention, compared with prior art with following advantage:
1st, present invention firstly discovers that through legionella pneumophilia ATCC33152 there is D-L types aminoacid to carry out configuration conversion, can make Standby highly purified l-amino acid.
2nd, method according to the present invention belongs to biological method, without using toxic chemical, to human body and environment almost without Harm.
3rd, method process is simple according to the present invention, with low cost, is adapted to industrialized production, it is possible to resolve amino acid products valency The prohibitively expensive problem of lattice.
Present invention is expanded on further by the following examples, and the scope of the present invention is not limited with embodiment.This It is bright to there are various known replacements in the art or deform, on the premise of without departing from essential meaning of the present invention, at this Within the protection domain of invention.
Description of the drawings:
Fig. 1:Manage the colonial morphology of the legionella pneumophilia for supporting adaptability screening.
Fig. 2:L-type cysteine electrochemistry differential pulse voltammetry(DPV)Curve.Curve 1:The L-type of 0.125mg/ml concentration Cysteine solution;Curve 2:With the negative control solution without L-type cysteine that method is prepared.
Fig. 3:L-type cysteine Electrochemical Detection standard curve(Ipmax vs Cmg/ml).
Fig. 4:Electrochemical method monitors the content of L-type cysteine.
Fig. 5:Nutrition flexibility screens the impact that the frequency changes yield to L-Cysteine.
Specific embodiment
Embodiment 1
Amino acid configuration conversion method according to the present invention is as follows:
1. the condition of culture of antibacterial
The fluid medium of suitable legionella fast-growth is prepared in accordance with the following methods.Weigh 10g N- (2- acetylaminos) -2- Aminoethane sulphonic acid (N- (2-Acetamido) -2-aminoethanesulfonic acid; ACES buffer);10g ferment During female extract (Yeast extract) is dissolved to 800mL distilled waters, pH value is adjusted to 6.9-7.0, high steam goes out Bacterium, cools down standby.In addition 5g bovin serum albumin (Bovin serum albumin), the Guang ammonia of 0.4g L- half are weighed respectively Sour (L-cysteine hydrochloride), 0.25g ferrous pyrophosphates (Ferrous pyrophosphate), fully In being dissolved in 200 mL distilled waters, by the microporous filter membrane sucking filtration in 0.22 μm of aperture it is degerming after, be added to it is above-mentioned sterilized it is standby Solution in, mixing is obtained final product.
2. the nutrition flexibility screening of strain
By legionella pneumophilia standard strain ATCC33152(Purchased from American Type Culture Collecti)It is inoculated in and is additionally supplemented with 10 % In the aforesaid liquid culture of D-L type cysteine, in 37 DEG C, 5% CO2Cultivate in incubator, every 7 days, draw 1mL and pass on Continue to cultivate into fresh above-mentioned culture medium, repeat aforesaid operations more than 10 times, you can obtain and have compared with homoamino acid configuration The strain of conversion efficiency.The mutant strain is properly preserved in into -70 DEG C of refrigerators standby.
3. antibacterial is passed on and propagation
Above-mentioned operation is supported after the actication of culture of adaptability screening, the fresh training of the liquid without D-L type cysteine is inoculated in In foster base (described in technique 1), in being placed in 37 DEG C of constant temperature track incubators, the h of 200rmp concussion and cultivates 48, to culture fluid The middle ammonium sulfate for adding isopyknic 3mol/L so as in albumen or enzyme be deposited to bottom, then it is centrifuged in 10000 rmp 30 min, thalline and albumen therein or enzyme are deposited in ttom of pipe, will precipitate wet body and collect, and are preserved in -70 DEG C of refrigerators It is standby.
4. amino acid configuration is changed and Product recycling
The racemic modification D-L type cysteine obtained to chemosynthesis is configured to aqueous solution, and it is heavy to be added thereto to above-mentioned wet body Starch(Comprising the protein ingredient in thalline and metabolite or other compositions), addition is 100 mg/mL, and solution is placed in 37 DEG C, the h of concussion and cultivate 24 in the shaking table of 200 rmp.Add isopyknic 3 mol/L ammonium sulfate in solution again, 10000 Rmp is centrifuged after 30 min, discards precipitation, and supernatant is processed by ion exchange, can harvest purity up to more than 97% L-type cysteine.
Embodiment 2
According to above-mentioned technique(Described in technique 2)The nutrition flexibility screening of strain is carried out, the legionella pneumophilia bacterial strain for being obtained exists Colony growth form on BCYE agar plates, is shown in Fig. 1.
Embodiment 3
The content of L-Cysteine in electrochemical methods monitoring transformation process
1. electrochemical behavior of the L-type cysteine on gold disc electrode
1.1. experimental technique:Prepare certain density L-type cysteine, qualitative detection its in three-electrode system(Working electrode: Gold disc electrode φ=5mm;Reference electrode:Saturated calomel electrode;To electrode:Platinum filament)In electrochemical behavior.
1.2. result and conclusion:See Fig. 2, DPV results show that L-Cysteine there are electrochemical signals on gold disc electrode surface Response, therefore be expected to build the content quantitative analysis method of the material.
Type cysteine content bioassay standard curve
2.1. experimental technique:0.5,0.25,0.125,0.0625,0.0313 is prepared respectively .... wait the L-type of 2 times of dilutions Aqueous cystein solution, carries out according to the method described above electrochemical gaging, and records maximum peak current(Ipmax)Value.With material concentration For abscissa, Ipmax For vertical coordinate, standard curve is made.
2.2. result and conclusion:Fig. 3 is seen, by standard curve it can be seen that Ipmax It is in line with the concentration of L-type cysteine Sexual intercourse.This method may be used to the changes of contents of L-type substance cysteine in detection sample.
According to electrochemistry DPV IpmaxThe changes of contents of L-type cysteine in value characterization processes
3.1. experimental technique:According to technique, the racemic modification D-L type cysteine that chemosynthesis are obtained is configured to into aqueous solution, And the mg/mL of wet body 100 described in technique thereto, 37 DEG C are placed in, the h of concussion and cultivate 24 in the shaking table of 200 rmp.When different Between section is separately sampled carries out the detection of electrochemistry DPV, the Ip that detection is obtainedmaxValue
Substitute into linear equation:Ipmax=32.468C+0.37642;Calculate the Guang ammonia of L-type half of differential responses time point in solution The content of acid.
3.2. result and conclusion:See Fig. 4, during transformation experiment, the content of L-type substance cysteine being continuously increased, Indicate DL type cysteine and be gradually transforming into single L-type conformation, after reaching 18 hours, substantially without increase, show conversion Reaction is basically completed.
Embodiment 4
The nutrition flexibility screening experiment of strain changes the impact of yield to L-Cysteine
3.1. experimental technique:According to technique 2, by difference pass on the screening frequency (0,1,2...10,11,12) harvest bacterium respectively Kind, then according to technique 3 and 4 carries out aminoacid transition experiment, further according to the method needed for example containing for L-type cysteine is calculated Amount, 13 batches of the frequency are passed on by being calculated difference(Batch)The yield of product(Yield)Percentage ratio.
3.2. result and conclusion:Fig. 5 is seen, by curve as can be seen that the yield percent of L-type cysteine is with passing on The increase of the frequency and increase, reach after passing on for 10 times, yield percent reaches higher level, and subsequent increasing degree is very low. Therefore, process choice passes at least 10 times.

Claims (3)

1. legionella thalline is used as the application for preparing amino acid configuration transferring reagent, it is characterised in that legionella thalline is used as one Amino acid configuration transferring reagent is planted, D-L type aminoacid is completely converted into into L-type aminoacid;Wherein described legionella thalline is Legionella pneumophilia ATCC33152.
2. used as the application for preparing amino acid configuration transferring reagent, its feature exists legionella thalline as claimed in claim 1 In described legionella thalline is bacterial strain Jing after Secondary Culture, the wet product obtained after centrifugation.
3. legionella thalline wet product as claimed in claim 2, it is characterised in that it includes legionella thalline, enzyme, albumen, core The composition produced during acid and growth metabolism.
CN201710088482.4A 2017-02-20 2017-02-20 Application of legionella thalli in preparing amino acid profile transformation agent Pending CN106676157A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710088482.4A CN106676157A (en) 2017-02-20 2017-02-20 Application of legionella thalli in preparing amino acid profile transformation agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710088482.4A CN106676157A (en) 2017-02-20 2017-02-20 Application of legionella thalli in preparing amino acid profile transformation agent

Publications (1)

Publication Number Publication Date
CN106676157A true CN106676157A (en) 2017-05-17

Family

ID=58861110

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710088482.4A Pending CN106676157A (en) 2017-02-20 2017-02-20 Application of legionella thalli in preparing amino acid profile transformation agent

Country Status (1)

Country Link
CN (1) CN106676157A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0346115B2 (en) * 1982-06-10 1991-07-15 Ajinomoto Kk
CN1592789A (en) * 2001-11-23 2005-03-09 Dsmip财产有限公司 Process for the preparation of an enantiomerically enriched alpha-amino acid
CN101974605A (en) * 2010-11-12 2011-02-16 南开大学 Method for preparing D-cystine by using microorganism enzymic method to split DL-cysteine
CN102417900A (en) * 2011-11-17 2012-04-18 天津启仁医药科技有限公司 ATC racemase and coding gene thereof, and application of recombinant expression protein thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0346115B2 (en) * 1982-06-10 1991-07-15 Ajinomoto Kk
CN1592789A (en) * 2001-11-23 2005-03-09 Dsmip财产有限公司 Process for the preparation of an enantiomerically enriched alpha-amino acid
CN101974605A (en) * 2010-11-12 2011-02-16 南开大学 Method for preparing D-cystine by using microorganism enzymic method to split DL-cysteine
CN102417900A (en) * 2011-11-17 2012-04-18 天津启仁医药科技有限公司 ATC racemase and coding gene thereof, and application of recombinant expression protein thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EWANN FANNY等: "Cysteine Metabolism in Legionella pneumophila:Characterization of an L-Cystine-Utilizing Mutant", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 *
PRICE CHRISTOPHER T. D.等: "Amoeba host-Legionella synchronization of amino acid auxotrophy and its role in bacterial adaptation and pathogenic evolution", 《ENVIRONMENTAL MICROBIOLOGY》 *
WARREN WJ等: "Growth of Legionnaires Disease Bacterium (Legionella pneumophila) in Chemically Defined Medium", 《JOURNAL OF CLINICAL MICROBIOLOGY》 *
胡建强等: "氨基酸手性拆分研究进展", 《食品与药品》 *
高吉: "氨肽酶B酶法拆分DL-氨基酸研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *

Similar Documents

Publication Publication Date Title
CN111304106B (en) Bacillus clausii and method for producing tetrahydropyrimidine by using same
CN106434510B (en) One plant of fermentation produces the genetic engineering bacterium of L-Aspartic acid
CN107267422B (en) Comamonas testosteroni HHALA-001 and method for producing L-alanine by using same
JPS58165786A (en) Variant of clostridium acetobutylicum with high productivity of buthanol and acetone and preparation thereof
EP0120369A2 (en) Production of acetic acid by a continuous fermentation process
CN110564580B (en) Method for producing vinegar containing pyrroloquinoline quinone through microbial co-culture fermentation
CN113957016B (en) Bacillus subtilis and method for preparing milk-flavored cordyceps sinensis fermentation liquor by using same
GARG et al. Continuous production of citric acid by immobilized whole cells of Aspergillus niger
CN106676157A (en) Application of legionella thalli in preparing amino acid profile transformation agent
CN116218690A (en) Curvularia robusta producing cloth Lei Feide bacteria A and fermentation method thereof
JPS59227294A (en) Pseudomonas microorganism and use thereof
KR101654793B1 (en) Bacillus subtilis BK418 with nitrogen fixation for soil and environmental improvement and cultivation methods thereof
JP4537862B2 (en) Highly efficient production method of organic acid by aerobic bacteria
KR101808429B1 (en) Device for microorganism isolation culture and re-use method of waste microbial culture medium
CN101481665B (en) Method for preparing 2,2-dimethyl cyclopropanecarboxamide and bacterial strain thereof by biological catalysis
CN109825452A (en) A method of screening degrading nitrite bacterial strain
CN113215064B (en) Slime bacterium for producing meishadazole compounds and application thereof
CN116426440B (en) Novel marine sulfur oxidizing bacteria strain and application thereof
JPH08256782A (en) Production of bacterium flocculant by fermentation method
JP2009148212A (en) Method for fermentatively producing mannitol and microorganism used for performance thereof
JP2849122B2 (en) Low temperature resistant Methanosarcina methanogen NY-927
CN105176954B (en) A kind of method that arginine deiminase is prepared using bacterial strain MQO-153
JP2016140322A (en) Electron mediator for electrical cultivation
CN105018453A (en) Method for preparation of arginase from strain MQO-154
JPH01112994A (en) Production of indoleacetic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170517